Evidence map›Paper›PMID 31941982›Full record

ArticleScientific reports2020

In silico study of the effects of anti-arrhythmic drug treatment on sinoatrial node function for patients with atrial fibrillation.

Jieyun Bai, Yaosheng Lu, Henggui Zhang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. In Silico Assessment of Class I Antiarrhythmic Drug Effects onInternational journal of molecular sciences · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jieyun BaiDepartment of Electronic Engineering, College of Information Science and Technology, Jinan University, Guangzhou, China. bai_jieyun@126.com.ORCID http://orcid.org/0000-0002-2847-350X
Yaosheng LuDepartment of Electronic Engineering, College of Information Science and Technology, Jinan University, Guangzhou, China.
Henggui ZhangBiological Physics Group, School of Physics & Astronomy, The University of Manchester, Manchester, United Kingdom. henggui.zhang@manchester.ac.uk.
Jinan University · CNUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sinus node dysfunction (SND) is often associated with atrial fibrillation (AF). Amiodarone is the most frequently used agent for maintaining sinus rhythm in patients with AF, but it impairs the sinoatrial node (SAN) function in one-third of AF patients. This study aims to gain mechanistic insights into the effects of the antiarrhythmic agents in the setting of AF-induced SND. We have adapted a human SAN model to characterize the SND conditions by incorporating experimental data on AF-induced electrical remodelling, and then integrated actions of drugs into the modified model to assess their efficacy. Reductions in pacing rate upon the implementation of AF-induced electrical remodelling associated with SND agreed with the clinical observations. And the simulated results showed the reduced funny current (I

Indexed as

Models, BiologicalAcetylcholineAmiodaroneAnti-Arrhythmia AgentsAtrial FibrillationHeart RateHumansIsoproterenolMembrane PotentialsReceptors, Adrenergic, betaSinoatrial NodeAcetylcholineAmiodaroneAnti-Arrhythmia AgentsIsoproterenolReceptors, Adrenergic, beta

Identifiers

PMID31941982
PMCPMC6962222
OpenAlexW2999485899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.